Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mette Bjerre

Showing results (71-80 of 112) with videos related to

Pageof 12
Sort By:
Cardiology|September 12, 2012
Osteoprotegerin predicts long-term outcome in patients with ST-segment elevation myocardial infarction treated with primary percutaneous coronary interventionSune Pedersen, Rasmus Mogelvang, Mette Bjerre, et al.
Cardiovascular Diabetology|July 8, 2022
Mannose-binding lectin does not explain the dismal prognosis after an acute coronary event in dysglycaemic patients. A report from the GAMI cohortSara Meziani, Giulia Ferrannini, Mette Bjerre, et al.
Cancers|January 27, 2021
Soluble PD-1 but Not PD-L1 Levels Predict Poor Outcome in Patients with High-Risk Diffuse Large B-Cell LymphomaHeli Vajavaara, Julie Bondgaard Mortensen, Suvi-Katri Leivonen, et al.
Heart (British Cardiac Society)|March 1, 2012
Osteoprotegerin and cardiovascular mortality in patients with non-ST elevation acute coronary syndromesRagnhild Røysland, Marc P Bonaca, Torbjørn Omland, et al.
The Journal of Clinical Endocrinology and Metabolism|September 24, 2019
Fibroblast Activation Protein is a GH Target: A Prospective Study of Patients with Acromegaly Before and After TreatmentMai C Arlien-Søborg, Camilla Grøndahl, Amanda Bæk, et al.
European Journal of Endocrinology|November 25, 2025
GH replacement therapy in adults stimulates fibroblast activation protein-α activityAmanda Bæk, Anne Kathrine Nissen Pedersen, Tine Borum Billeskov, et al.
Clinical Biochemistry|January 7, 2015
Dynamic changes in sRAGE levels and relationship with cardiac function in STEMI patientsLouise J N Jensen, Søren Lindberg, Søren Hoffmann, et al.
Journal of Pediatric Gastroenterology and Nutrition|January 13, 2016
Spray Dried, Pasteurised Bovine Colostrum Protects Against Gut Dysfunction and Inflammation in Preterm PigsAnn Cathrine F Sty, Per T Sangild, Kerstin Skovgaard, et al.
Scandinavian Journal of Clinical and Laboratory Investigation|July 16, 2014
Osteoprotegerin independently predicts mortality in patients with stable coronary artery disease: the CLARICOR trialMette Bjerre, Jørgen Hilden, Jens Kastrup, et al.
The Journal of Invasive Cardiology|January 8, 2009
Level of complement activity predicts cardiac dysfunction after acute myocardial infarction treated with primary percutaneous coronary interventionSune Haahr-Pedersen, Mette Bjerre, Allan Flyvbjerg, et al.
Pageof 12

Showing results (71-80 of 112) with videos related to

Sort By:
Pageof 12
Cardiology|September 12, 2012
Osteoprotegerin predicts long-term outcome in patients with ST-segment elevation myocardial infarction treated with primary percutaneous coronary interventionSune Pedersen, Rasmus Mogelvang, Mette Bjerre, et al.
Cardiovascular Diabetology|July 8, 2022
Mannose-binding lectin does not explain the dismal prognosis after an acute coronary event in dysglycaemic patients. A report from the GAMI cohortSara Meziani, Giulia Ferrannini, Mette Bjerre, et al.
Cancers|January 27, 2021
Soluble PD-1 but Not PD-L1 Levels Predict Poor Outcome in Patients with High-Risk Diffuse Large B-Cell LymphomaHeli Vajavaara, Julie Bondgaard Mortensen, Suvi-Katri Leivonen, et al.
Heart (British Cardiac Society)|March 1, 2012
Osteoprotegerin and cardiovascular mortality in patients with non-ST elevation acute coronary syndromesRagnhild Røysland, Marc P Bonaca, Torbjørn Omland, et al.
The Journal of Clinical Endocrinology and Metabolism|September 24, 2019
Fibroblast Activation Protein is a GH Target: A Prospective Study of Patients with Acromegaly Before and After TreatmentMai C Arlien-Søborg, Camilla Grøndahl, Amanda Bæk, et al.
European Journal of Endocrinology|November 25, 2025
GH replacement therapy in adults stimulates fibroblast activation protein-α activityAmanda Bæk, Anne Kathrine Nissen Pedersen, Tine Borum Billeskov, et al.
Clinical Biochemistry|January 7, 2015
Dynamic changes in sRAGE levels and relationship with cardiac function in STEMI patientsLouise J N Jensen, Søren Lindberg, Søren Hoffmann, et al.
Journal of Pediatric Gastroenterology and Nutrition|January 13, 2016
Spray Dried, Pasteurised Bovine Colostrum Protects Against Gut Dysfunction and Inflammation in Preterm PigsAnn Cathrine F Sty, Per T Sangild, Kerstin Skovgaard, et al.
Scandinavian Journal of Clinical and Laboratory Investigation|July 16, 2014
Osteoprotegerin independently predicts mortality in patients with stable coronary artery disease: the CLARICOR trialMette Bjerre, Jørgen Hilden, Jens Kastrup, et al.
The Journal of Invasive Cardiology|January 8, 2009
Level of complement activity predicts cardiac dysfunction after acute myocardial infarction treated with primary percutaneous coronary interventionSune Haahr-Pedersen, Mette Bjerre, Allan Flyvbjerg, et al.
Pageof 12